Premium
Characterization of nociceptin hyperalgesia and allodynia in conscious mice
Author(s) -
Hara Naoki,
Minami Toshiaki,
OkudaAshitaka Emiko,
Sugimoto Tetsuo,
Sakai Masato,
Onaka Masahiko,
Mori Hidemaro,
Imanishi Toshihiro,
Shingu Koh,
Ito Seiji
Publication year - 1997
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0701146
Subject(s) - nociceptin receptor , allodynia , chemistry , pharmacology , hyperalgesia , receptor antagonist , agonist , muscimol , nmda receptor , antagonist , endocrinology , medicine , opioid , receptor , nociception , opioid peptide , biochemistry
Intrathecal (i.t.) administration of nociceptin and high doses of morphine induced allodynia in response to innocuous tactile stimuli, and i.t. nociceptin evoked hyperalgesia in response to noxious thermal stimuli in conscious mice. Here we have characterized the nociceptin‐induced allodynia and compared it with the morphine‐induced allodynia and the nociceptin‐evoked hyperalgesia. Nociceptin‐induced allodynia was evoked by the first stimulus 5 min after i.t. injection, reached a maximum at 10 min, and continued for a 50 min experimental period. Dose‐dependency of the allodynia showed a bell‐shaped pattern from 50 pg to 5 ng kg −1 , and the maximum effect was observed at 2.5 ng kg −1 . Morphine‐induced allodynia reached the maximum effect at 15 min and declined progressively until cessation by 40–50 min. The dose‐response curve showed a bell‐shaped pattern, similar to that induced by nociceptin, with a maximum effect at 0.5 mg kg −1 , five orders of magnitude higher than that of nociceptin. The allodynia evoked by nociceptin and morphine were dose‐dependently blocked by glycine, D (−)‐2‐amino‐5‐phosphonovaleric acid ( D ‐AP5, an N ‐methyl‐ D ‐aspartate (NMDA) receptor antagonist), γ‐ D ‐glutamylaminomethyl sulphonic acid (GAMS, a non‐NMDA receptor antagonist) and methylene blue (a soluble guanylate cyclase inhibitor), but were not affected by muscimol (a γ‐aminobutyric acid A (GABA A ) receptor agonist) and baclofen (a GABA B receptor agonist). Morphine did not inhibit forskolin‐stimulated cyclicAMP formation in cultured cells expressing the nociceptin receptor. Nociceptin‐induced hyperalgesia was evoked 10–15 min after i.t. injection. Nociceptin produced a monophasic hyperalgesic action over a wide range of doses from 5 fg to 50 ng kg −1 . The nociceptin‐induced hyperalgesia was blocked by glycine only among the agents examined. None of the pain responses evoked by nociceptin and morphine were blocked by naloxone. These results demonstrate that, whereas the mechanisms of the nociceptin‐induced allodynia and hyperalgesia are evidently distinct, they involve a common neurochemical event beginning with the disinhibition of the inhibitory glycinergic response. Morphine may induce allodynia through a pathway common to nociceptin, but the nociceptin receptor does not mediate the action of high doses of morphine.